{"name":"Juventas Cell Therapy Ltd.","slug":"juventas-cell-therapy-ltd","ticker":"","exchange":"","domain":"juventascelltherapy.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPRGdOSUR3S1F3TjNiLWtyb09MbmpmMmhmMFpYcmZqempEWWtIVVBVWkNZSUlva1c5bE15QnFBbmhZZ3o3dktuZHhkUFRUdlZFdDlfd3JCeVcyaEtIVzV4aDlIcVFwX19rdnJkSkVwOExHVzhTdlJyTEtTYTZrQlVRdHF3RG9xYWhUTmxMektrUWVoSjU1RUVKQXEzWjg0N25QcFQ1cl9qMDVKS1FneDJhWmQ4cE5pVDMwT1lEeWhMeVB0UQ?oc=5","date":"2025-12-01","type":"regulatory","source":"BioPharma APAC","summary":"Juventas’ CAR-T Therapy Ina-cel Receives NMPA Approval for Large B-Cell Lymphoma - BioPharma APAC","headline":"Juventas’ CAR-T Therapy Ina-cel Receives NMPA Approval for Large B-Cell Lymphoma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxOdG5HU0kwZUNwSWpYcl8wQmNEMGg1a2gya0lRN1c5SDFfWDUtZzU0ZTdtUEw2TXI2YzRpMG91NHJuYW9rZF9TUldVaHR1MU5GUkdndDF2THo1SHhna1RXXzJ1UVN2VWdqX1kxeU52dmlQeGJrd3QwZmktV3NYa3pzcjVBSTMtNGNPZU9YdHZyUXJnaFYxdlFtRElHazdzem5KMVZwY3F1WkRCMEd5eTE2b2NFNXZTMHhPT2dzc2pkLVNaYTBEdnF2OFJVbXpGM0d2eDVwSXhYMUxXcVEtT2IzaG9aYWZHLXkz?oc=5","date":"2025-01-06","type":"regulatory","source":"CRISPR Medicine News","summary":"Press Release Service: CAR-T Cell Therapy Market Research 2024-2025: Size, Forecasts, Trials, and Trends - Approved CAR-T Therapies and Late-stage Clinical Trials that Could Reach Commercialization So","headline":"Press Release Service: CAR-T Cell Therapy Market Research 2024-2025: Size, Forecasts, Trials, and Trends - Approved CAR-","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQbUNZYXNKSVY0T0l2ZXdmdW92bmVHcWVzUmFzM3FSbG5IeVBuZG1OazJFaERNMmMzNG4tT1JHS3ZrWVk1b1c0aTlINHdSQkRqa1JVdzZ6d2xIT2UxejNKeVAzTUx6Z0Y2NzdZc015dzRINGp6UUprYTR0NXZzMUpkeVZWa2t3Sm9pVjNOQ2h3S0F0cDJYS0JEeG5iQ0U?oc=5","date":"2024-04-24","type":"pipeline","source":"BioWorld News","summary":"China grapples with providing access to CAR T therapies - BioWorld News","headline":"China grapples with providing access to CAR T therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNSXpfdHZUQWdBdm1Cc01xQjhaUVNudUFBVjU1MDNJa0hiSlBjb25aOEJleEVuOW5DV1FHSzRUUHpUSXlkSFZ4bnBKTHB0VlBhbVUwWjRieEU3ZC0wZDdIOVdpbmlDWjZtbV9jMTlFS1g5bHp5eDhsV21lMHhSanlVYW9ZT0plSVg5djlrUGVOUlZJcFhXQlBTa28zWllkUDlWTmRNODZtYw?oc=5","date":"2024-04-23","type":"pipeline","source":"BioWorld News","summary":"CAR T pipelines bloom to treat world’s largest cancer population - BioWorld News","headline":"CAR T pipelines bloom to treat world’s largest cancer population","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOYmNHY1BHeW9pVVpSaXZqT2ZtNHpZY01jdEZqdl9KZE5mUVNnR21icHBnN2UyYXNzMkZLU3RVdG5LZl9fQ01hWW01TGpJQVpwQk4wc25PZXF3R2JuSU91dVpMcUh4ek1seHVja3kzV043WERYbHpMZG5fX05yYzkxWmkxSXREV3FIZkt1VDd3bkhXTkpwbjdNZjd2cGF2bG9Ea3B1cVFoQlEtUzdC?oc=5","date":"2024-04-22","type":"trial","source":"BioWorld News","summary":"China’s investigator trials accelerate competitive CAR T development - BioWorld News","headline":"China’s investigator trials accelerate competitive CAR T development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOZTJxY3IxVWdDRWY1c3lVYlRaejFsYTBVc3JsOE9Zbk1Oc0lYb2hUNkItLWp5QXBLcDNQSlk4RHJMdzdMNGNfSmJLRUxVNHJiQmtrcVMxalJQc0JHamJpYUZGVkpGZkpWWWpjRzJpUkhQVEprUWlNQXUtWk0taTVQS09fN1hRd285bk90TEh0SXVvUWxlNnZCQkxuSQ?oc=5","date":"2023-11-08","type":"regulatory","source":"BioSpace","summary":"CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA - BioSpace","headline":"CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2023-05-31","type":"trial","source":"GlobeNewswire","summary":"B-Cell Lymphoma Clinical Trial Pipeline Insights: - GlobeNewswire","headline":"B-Cell Lymphoma Clinical Trial Pipeline Insights:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQUWZuZFlyV3l6Y255ZE12ZlhjUXhnVko4WUR2Rk1abnk0bDVtbnlYckJNZ3NIMWdWWXJTZEtDcFRwU00tVlh6RVg3R1M1ZzhFdVlZUzhpbGlUdGFraGIzVTJKSDNUY1U3QjNkQzgwX1NycGZDMGs4cmxHcUhnQlFZUXl0TW1mVjZ0d1JpTHJMejg2WVp5YlljV2hfSno5YzVSR0ZGYUZkQl94OUxvamFXSE9vdEEydlpGejNkbXBzbFFKTDg0VFliNnA4U0NmZDNRNTBfa3RaQ19wdw?oc=5","date":"2022-09-23","type":"pipeline","source":"PR Newswire","summary":"CASI PHARMACEUTICALS ANNOUNCES EXIT OF JUVENTAS INVESTMENT TO STRENGTHEN BALANCE SHEET - PR Newswire","headline":"CASI PHARMACEUTICALS ANNOUNCES EXIT OF JUVENTAS INVESTMENT TO STRENGTHEN BALANCE SHEET","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxPb05BRGhlWGtVSzNvZFZicnRDeDZ2Q3ZVSlktelNma3ZDbEJlVnNVUHY5ckh4Y3ZETE1zRmw2bnZzdnFLdUI2elJvMmhJVU0xeWhYRXhqcU81NEVMejM2NjhXQlBKd2tsc3VYWkc3cldZbTZ6RVp6aGNKVHVPUTZOWDh1VXVUdV90WFVUd21aNFlHTFVSdjRiZnVxYWlsb09Tdi1hQ3VtNTRTN19FZ3ZjUWZwTjhRaGdsQ2dTUTRWUktwMFBkb2hQcWdBWGJFcHk4UEE2WEEyclE1eU9FbGNCNENGX1gzTTE4cFhVUWtmeXd3WjVaNVV6VDl4c3daMmlNakNTWXlteUdTVWlPVmx0SzRTQkFXMWpPbC1WcVNtZDVFZWRLUXV5Z3hfTUZQa0pDcHU0YlotUG5KRlFLMnpnOEdrY3J3ZU1CS0NqcHhB?oc=5","date":"2021-10-25","type":"trial","source":"PR Newswire","summary":"CASI Pharmaceuti­­­cals Announces Partner Juventas Completion Of Series C Financing Of $63 Million (RMB410 Million) For Acceleration Of CNCT19 Pivotal Trials And Commercialization - PR Newswire","headline":"CASI Pharmaceuti­­­cals Announces Partner Juventas Completion Of Series C Financing Of $63 Million (RMB410 Million) For ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNU2xkYXdKZzNRbzFqclZ4bTIxWlp6UEdwck5ia1h2Q3duZ2xqXzZqUjJBXzBvTkpxX3pQU3UtazY0cy1WOHNIVUc3d0FKbGozZHE2akx0V3ZhSDB0c0gwUkJ6NUFyX3FGRXh6OGx2M3c1UmZrTmYwUFc0YVc1dzRqdE9nbURnTjJ2MnZmWkNsQkUzTkp4QjA5dXVOLWtXc1pucnc5M1ZDODRzaHR0QUhmTTZIeElneFd3eUFwMThfYXBrNENiS2poSU5sbjZvc0h5bTdCTDJQV01fZ1VnTnlz?oc=5","date":"2020-09-29","type":"deal","source":"PR Newswire","summary":"CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy Ltd - PR Newswire","headline":"CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy Ltd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYmlqT0ZMQmVMQWdFN3hENHR4VmlEN3FJdUdYcm5zOW05YWg1X0piZlNWbWcwbVhIYVlMWEtUdU5QV0sxMUlkQ3Vack1OX0FCWnFLNUpLOS1BVURrYTNaaXlGekpIcXFXOU8tQWExbU4wUGtqMHJGRnJpa3JyZkpDczFqNzlWRHVlWHM1OVVueG03bmp1TjNxY0lscEJhQ3BYWXBRQ2FiZ1l6dGRhSmFWTFRzeXZBTk5rRFAyVnZTQ1BjcEFpLVplSGhzWmFCOVh2RnVQRk5qQmNXZzVV?oc=5","date":"2019-06-17","type":"deal","source":"PR Newswire","summary":"CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy - PR Newswire","headline":"CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}